Radisens is developing a high sensitivity quantitative point-of-care in-vitro diagnostics platform – Gemini™ – to measure Ferritin (iron stores) in at-risk blood donors before they donate. A point-of-care Ferritin measurement has the …

Radisens is developing a professional-use only, point-of-care in-vitro diagnostics platform – Gemini™ – to quantify Ferritin levels in at-risk blood donors before blood donation. Gemini™ consists of an optical-based reader which automatically tests  …

Radisens has a business-to-business commercial approach and seek to develop strategic partnerships. These include technology licensing,  manufacture and distribution with collaborators in the monitoring of iron stores within blood …